Table 1.
Participant demographics and clinical characteristics
|
Characteristics |
AD |
CN |
p-value |
Test |
|---|---|---|---|---|
| (N = 40) | (N = 38) | |||
| Mean Age +/- SD |
69.0 +/- 9.1 |
69.5 +/- 9.7 |
0.825 |
T |
| Mean Years of Education +/- SD |
14.8 +/- 3.6 |
16.6 +/- 3.0 |
0.015 |
T |
| Mean MMSE +/- SD |
19.9 +/- 7.7 |
29.2 +/- 1.3 |
1.0E-9 |
T |
| % Male |
25.0 |
34.21 |
0.459 |
F |
| % Caucasian |
82.5 |
86.8 |
1.00 |
F |
| % Taking Antidepressant |
30.0 |
21.05 |
0.441 |
F |
| % Taking Antipsychotic |
5.0 |
0.0 |
0.494 |
F |
| % Taking Anxioytic |
12.5 |
13.2 |
1.00 |
F |
| % Taking Corticosteroids |
2.5 |
13.2 |
0.104 |
F |
| % Taking Cholinesterase Inhibitor |
37.5 |
0.0 |
<1.0E-9 |
F |
| % Taking Memantine |
15.0 |
0.0 |
0.026 |
F |
| % Taking Statins | 20.0 | 26.3 | 0.595 | F |
Abbreviations: AD Alzheimer’s disease, CN Normal cognition, SD Standard Deviation, T two-sample t test, two-sided, MMSE Mini-Mental State Exam obtained at date closest to sample if not available concurrently, F Fisher’s exact test, two-sided.